You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibrostenotic Crohn's Disease Trial (AGMB-129, Placebo)

Not yet recruiting
  • Fibrostenotic Crohn's Disease
  • (no location specified)
May 3, 2023

Cytokines and Genes in Therapeutic Response in Crohn's Disease

Completed
  • Inflammatory Bowel Diseases
  • Baseline blood sample
  • +6 more
  • Nashville, Tennessee
  • +1 more
May 4, 2022

Crohn Disease, Pediatric Crohns Disease Trial in Bron (Blood samples, Biopsies)

Not yet recruiting
  • Crohn Disease
  • Pediatric Crohns Disease
  • Blood samples
  • Biopsies
  • Bron, France
    Service Hépatologie, Gastroentérologie et Nutrition pédiatrique,
Apr 24, 2023

Crohn Disease Trial in Cleveland, Miskolc, Madrid (Ozanimod)

Not yet recruiting
  • Crohn Disease
  • Cleveland, Ohio
  • +2 more
Jul 21, 2022

Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

Not yet recruiting
  • Crohn Disease
  • +4 more
  • TDM-based infliximab intravenous therapy
  • Standard infliximab intravenous therapy
  • (no location specified)
Sep 26, 2023

Validation of an IUS Activity Index

Not yet recruiting
  • Crohn Disease
  • Ultrasound, Colonoscopy, MRE
  • Berlin, Germany
    IBUS office
Jun 2, 2022

Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)

Not yet recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • Vedolizumab IV
  • Vedolizumab SC
  • (no location specified)
Oct 17, 2023

Crohn's Disease Trial (Risankizumab)

Not yet recruiting
  • Crohn's Disease
  • (no location specified)
Aug 10, 2023

Disease Activity and Adverse Events in Adolescent and Adult

Recruiting
  • Crohn's Disease
    • Toyota-shi, Aichi, Japan
    • +1 more
    Aug 29, 2023

    Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

    Not yet recruiting
    • Crohn's Disease
    • Risankizumab SC
    • Placebo for risankizumab
    • (no location specified)
    Sep 26, 2023

    Upper Gastrointestinal Tract of Crohn's Disease

    Completed
    • Crohn Disease
    • General variables
    • +3 more
    • Terrassa, Barcelona, Spain
      Hospital Universitari Mutua Terrassa
    May 23, 2023

    IBD, Crohn Disease, Ulcerative Colitis Trial in Adelaide (ATH-063, Placebo)

    Recruiting
    • Inflammatory Bowel Diseases
    • +3 more
    • Adelaide, South Australia, Australia
      CMAX Clinical Research
    Apr 10, 2023

    Remote Monitoring of IBD

    Recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • patient reported outcome measures
    • +2 more
    • Den Bosch, Netherlands
    • +4 more
    May 23, 2023

    Pediatric Inflammatory Bowel Diseases Using Multispectral

    Not yet recruiting
    • Crohn Disease
    • +2 more
    • Multispectral Optoacoustic Tomography
    • (no location specified)
    Oct 24, 2023

    Crohn Disease Trial (Investigational Product, Placebo)

    Not yet recruiting
    • Crohn Disease
    • Investigational Product
    • Placebo
    • (no location specified)
    Jul 20, 2022

    Comorbidity Index in Crohn's Disease

    Not yet recruiting
    • Crohn Disease
      • Vandoeuvre-lès-Nancy, France
      • +1 more
      Feb 22, 2022

      Crohn Disease Trial in Worldwide (BI 706321, ustekinumab, Placebo)

      Recruiting
      • Crohn Disease
      • BI 706321
      • +2 more
      • Northridge, California
      • +30 more
      Aug 2, 2022

      IBD, Crohn Disease, Ulcerative Colitis Trial in Orléans (Blood and fecal samples, Coolonic biopsies)

      Recruiting
      • Inflammatory Bowel Diseases
      • +2 more
      • Blood and fecal samples
      • Coolonic biopsies
      • Orléans, France
        CHR Orléans
      Jun 14, 2023

      Subcutaneous HUMIRA Injection to Assess Adverse Events and

      Recruiting
      • Crohn's Disease
        • Beijing, Beijing, China
        • +8 more
        Jan 12, 2023

        Crohn Disease, Colitis, Ulcerative Trial (TEV-48574 Dose Regimen A, TEV-48574 Dose Regiment B)

        Recruiting
        • Crohn Disease
        • Colitis, Ulcerative
        • TEV-48574 Dose Regimen A
        • TEV-48574 Dose Regiment B
        • Kissimmee, Florida
          Teva Investigational Site 15357
        Feb 2, 2023

        Volatile Organic Compounds in Active Inflammatory Bowel Disease

        Recruiting
        • IBD
        • +2 more
        • Breath Test
        • Cleveland, Ohio
          Cleveland Clinic
        Sep 4, 2022

        Crohn Disease, Colitis, Ulcerative Trial (TEV-48574, Placebo)

        Not yet recruiting
        • Crohn Disease
        • Colitis, Ulcerative
        • (no location specified)
        Aug 11, 2022

        Crohn Disease, Bowel Cleansing, Apparent Diffusion Coefficient Trial in Amiens (MR-enterography)

        Recruiting
        • Crohn Disease
        • +2 more
        • MR-enterography
        • Amiens, France
          CHU Amiens
        May 3, 2022

        Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)

        Completed
        • Ulcerative Colitis (UC)
        • Crohn's Disease
        • Coronado, California
        • +5 more
        Oct 20, 2022

        Disease Bowel, Crohn Disease, Ulcerative Colitis Trial in France (Sleep activity, Questionnaires)

        Not yet recruiting
        • Disease Bowel
        • +2 more
        • Sleep activity
        • Questionnaires
        • Clermont-Ferrand, France
        • +3 more
        Apr 28, 2023